$ARIA Recent News Six stocks to watch 3:27 p.m
Post# of 144491
Posted On: 11/10/2014 10:06:37 AM
$ARIA Recent News
Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
10-Q: ARIAD PHARMACEUTICALS INC 4:53 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals 8:58 a.m. Nov. 6, 2014 - benzinga.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2014 Results - Earnings Call Transcript 12:47 p.m. Nov. 5, 2014 - Seeking Alpha
Ariad updates guidance after Q3 results 9:49 a.m. Nov. 5, 2014 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Nov. 5, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. Nov. 4, 2014 - Seeking Alpha
Will ARIAD (ARIA) Miss This Earnings Season? - Analyst Blog 5:00 p.m. Nov. 4, 2014 - Zacks.com
CHMP says Iclusig OK to use as is, advises revised label 10:26 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP ARIA ANAC CLDX 8:30 a.m. Oct. 20, 2014 - InvestorPlace.com
ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today 9:45 a.m. Oct. 16, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ARIA CLVS HZNP CBPO 1:00 p.m. Oct. 15, 2014 - InvestorPlace.com
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog 5:05 p.m. Oct. 14, 2014 - Zacks.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog 5:55 p.m. Oct. 13, 2014 - Zacks.com
EMA's PRAC backs Iclusig 9:21 a.m. Oct. 10, 2014 - Seeking Alpha
ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog 5:49 p.m. Oct. 6, 2014 - Zacks.com
Ariad restructures license agreement with Bellicum 9:30 a.m. Oct. 6, 2014 - Seeking Alpha
Wayfair Rises, Westport Innovations Cuts Forecast 8:30 a.m. Oct. 6, 2014 - FOXBusiness
ARIAD Pharmaceuticals' All-In Bet On Europe 11:18 a.m. Oct. 5, 2014 - Seeking Alpha
Free Fall Continues For Freddie Mac, Fannie Mae 12:44 p.m. Oct. 2, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARIA CLVS THRX MYL 8:00 a.m. Oct. 2, 2014 - InvestorPlace.com
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 9:44 a.m. Nov. 6, 2014 - BusinessWire - BZX
ARIAD Reports Third Quarter 2014 Financial Results and Development Progress 7:36 a.m. Nov. 5, 2014 - BusinessWire - BZX
ARIAD to Present at the Stifel 2014 Healthcare Conference 7:35 a.m. Nov. 4, 2014 - BusinessWire - BZX
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe 6:35 a.m. Oct. 24, 2014 - BusinessWire - BZX
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 7:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 7:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results 6:35 a.m. Oct. 15, 2014 - BusinessWire - BZX
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency 6:44 a.m. Oct. 10, 2014 - BusinessWire - BZX
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology 6:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib 6:35 a.m. Oct. 2, 2014 - BusinessWire - BZX
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 6:35 a.m. Sept. 29, 2014 - BusinessWire - BZX
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 11:41 a.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 7:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 10:34 p.m. Aug. 6, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel 6:36 a.m. Aug. 5, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 6:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 6:35 a.m. July 14, 2014 - BusinessWire - BZX
Six stocks to watch 3:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 3:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 9:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 1:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 3:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
10-Q: ARIAD PHARMACEUTICALS INC 4:53 p.m. Nov. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals 8:58 a.m. Nov. 6, 2014 - benzinga.com
Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2014 Results - Earnings Call Transcript 12:47 p.m. Nov. 5, 2014 - Seeking Alpha
Ariad updates guidance after Q3 results 9:49 a.m. Nov. 5, 2014 - Seeking Alpha
ARIAD Pharmaceuticals (ARIA) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Nov. 5, 2014 - Seeking Alpha
Notable earnings before Wednesday’s open 5:30 p.m. Nov. 4, 2014 - Seeking Alpha
Will ARIAD (ARIA) Miss This Earnings Season? - Analyst Blog 5:00 p.m. Nov. 4, 2014 - Zacks.com
CHMP says Iclusig OK to use as is, advises revised label 10:26 a.m. Oct. 24, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – NPSP ARIA ANAC CLDX 8:30 a.m. Oct. 20, 2014 - InvestorPlace.com
ARIAD Pharmaceuticals (ARIA) Showing Signs Of Perilous Reversal Today 9:45 a.m. Oct. 16, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – ARIA CLVS HZNP CBPO 1:00 p.m. Oct. 15, 2014 - InvestorPlace.com
ARIAD's Iclusig Gains Positive Recommendation from PRAC - Analyst Blog 5:05 p.m. Oct. 14, 2014 - Zacks.com
Amgen's Blinatumomab Gets Priority Review in the U.S. - Analyst Blog 5:55 p.m. Oct. 13, 2014 - Zacks.com
EMA's PRAC backs Iclusig 9:21 a.m. Oct. 10, 2014 - Seeking Alpha
ARIAD Gets Breakthrough Therapy Designation for AP26113 - Analyst Blog 5:49 p.m. Oct. 6, 2014 - Zacks.com
Ariad restructures license agreement with Bellicum 9:30 a.m. Oct. 6, 2014 - Seeking Alpha
Wayfair Rises, Westport Innovations Cuts Forecast 8:30 a.m. Oct. 6, 2014 - FOXBusiness
ARIAD Pharmaceuticals' All-In Bet On Europe 11:18 a.m. Oct. 5, 2014 - Seeking Alpha
Free Fall Continues For Freddie Mac, Fannie Mae 12:44 p.m. Oct. 2, 2014 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – ARIA CLVS THRX MYL 8:00 a.m. Oct. 2, 2014 - InvestorPlace.com
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 9:44 a.m. Nov. 6, 2014 - BusinessWire - BZX
ARIAD Reports Third Quarter 2014 Financial Results and Development Progress 7:36 a.m. Nov. 5, 2014 - BusinessWire - BZX
ARIAD to Present at the Stifel 2014 Healthcare Conference 7:35 a.m. Nov. 4, 2014 - BusinessWire - BZX
ARIAD Announces Adoption of Final Opinion for Iclusig by Committee for Medicinal Products for Human Use in Europe 6:35 a.m. Oct. 24, 2014 - BusinessWire - BZX
Insider Trading Alerts for Micron, CSX, Ariad Pharmaceuticals, IBM, SinoCoking Coal and Coke Chemical, and MannKind 7:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Insider Trading Research for Halliburton, Ariad Pharmaceuticals, KeyCorp, GoPro, MannKind, and Plug Power 7:45 a.m. Oct. 20, 2014 - PR Newswire - PRF
Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics 7:40 a.m. Oct. 15, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results 6:35 a.m. Oct. 15, 2014 - BusinessWire - BZX
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency 6:44 a.m. Oct. 10, 2014 - BusinessWire - BZX
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology 6:35 a.m. Oct. 6, 2014 - BusinessWire - BZX
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer Resistant to Crizotinib 6:35 a.m. Oct. 2, 2014 - BusinessWire - BZX
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 6:35 a.m. Sept. 29, 2014 - BusinessWire - BZX
INNATE PHARMA APPOINTS PIERRE DODION AS CHIEF MEDICAL OFFICER AND MEMBER OF THE EXECUTIVE COMMITTEE 11:41 a.m. Sept. 16, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 7:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 12:19 p.m. Aug. 19, 2014 - PR Newswire - PRF
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress 10:34 p.m. Aug. 6, 2014 - BusinessWire - BZX
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel 6:36 a.m. Aug. 5, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 8:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 6:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 6:35 a.m. July 14, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼